MedPath

West China Hospital of Sichuan University (Sichuan International Hospital)

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Effect of Lidocaine on Postoperative Pain and Long-term Survival in Elderly Patients Undergoing Colorectal Surgery

Not Applicable
Recruiting
Conditions
Colorectal Cancer
Interventions
Drug: Placebo
First Posted Date
2024-05-08
Last Posted Date
2024-05-08
Lead Sponsor
West China Hospital
Target Recruit Count
276
Registration Number
NCT06405776
Locations
🇨🇳

China, Sichuan, China

Individualized ANH for Non-cardiac Surgery

Not Applicable
Recruiting
Conditions
Hemodilution
Transfusion Related Complication
Interventions
Procedure: Individualized ANH
First Posted Date
2024-05-03
Last Posted Date
2024-12-04
Lead Sponsor
West China Hospital
Target Recruit Count
40
Registration Number
NCT06399536
Locations
🇨🇳

West China Hospital of Sichuan University, Chengdu, Sichuan, China

Prognostic Effect of Body Composition in Cancer Survivors

Completed
Conditions
Body Composition
Morality
Cancer Survivor
First Posted Date
2024-05-03
Last Posted Date
2024-05-03
Lead Sponsor
West China Hospital
Target Recruit Count
1500
Registration Number
NCT06398782

Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer

Not yet recruiting
Conditions
Non-small Cell Lung Cancer Stage ⅢA
Non-small Cell Lung Cancer Stage IIIB
Interventions
Other: cycles of neoadjuvant therapy and duration of waiting for surgery
First Posted Date
2024-05-01
Last Posted Date
2024-05-01
Lead Sponsor
West China Hospital
Target Recruit Count
250
Registration Number
NCT06394427

Lactobacillus Rhamnosus GG Alleviates Oral Mucositis in Patients Undergoing Radiotherapy

Not Applicable
Recruiting
Conditions
Oral Mucositis
Interventions
Dietary Supplement: Placebo-containing tablets
Dietary Supplement: Lactobacillus rhamnosus GG powder
Radiation: Radiotherapy
First Posted Date
2024-04-30
Last Posted Date
2024-04-30
Lead Sponsor
West China Hospital
Target Recruit Count
132
Registration Number
NCT06390176
Locations
🇨🇳

West China Hospital, Sichuan University, Chengdu, Sichuan, China

SHR-8068 Combined With Adbelizumab and BP102 in the Treatment of Advanced Colorectal Cancer

Phase 1
Not yet recruiting
Conditions
Colorectal Cancer
Interventions
First Posted Date
2024-04-18
Last Posted Date
2024-04-18
Lead Sponsor
West China Hospital
Target Recruit Count
36
Registration Number
NCT06373133

Decade-Long Insights Into Transperineal Prostate Biopsy in a West China Population

Not yet recruiting
Conditions
Prostate Cancer
Pathology
First Posted Date
2024-04-15
Last Posted Date
2024-04-16
Lead Sponsor
West China Hospital
Target Recruit Count
10000
Registration Number
NCT06366308

AI App for Management of Atopic Dermatitis

Not Applicable
Recruiting
Conditions
Atopic Dermatitis
Artificial Intelligence
Interventions
Behavioral: Artificial Intelligence assistant decision-making system (AIADMS) App
First Posted Date
2024-04-12
Last Posted Date
2024-10-11
Lead Sponsor
West China Hospital
Target Recruit Count
232
Registration Number
NCT06362629
Locations
🇨🇳

West China Hospital, Sichuan University, Chengdu, Sichuan, China

Physical Activity and Nutrition in Cancer Survivors

Completed
Conditions
Cancer
Nutrition, Healthy
Physical Inactivity
First Posted Date
2024-04-05
Last Posted Date
2024-04-05
Lead Sponsor
West China Hospital
Target Recruit Count
3100
Registration Number
NCT06350214

Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer

Phase 2
Not yet recruiting
Conditions
Gastric Cancer
Interventions
Drug: Nab-paclitaxel Combined With Cadonilimab (AK104)
First Posted Date
2024-04-05
Last Posted Date
2024-04-05
Lead Sponsor
West China Hospital
Target Recruit Count
59
Registration Number
NCT06349967
© Copyright 2025. All Rights Reserved by MedPath